When Emma was diagnosed with triple-negative breast cancer, she didn't let it define her. There are so many ways cancer steals possibility, but at Gilead, we’re helping take it back.
GileadNews: We’re joining with Kite Pharma to announce the presentation of transformative cancer research at this year’s American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) annual meetings.
“Living with primary biliary cholangitis (PBC) can be an isolating experience,” explains Dilek, a mother of two from Germany who suffers from the rare chronic liver disease.
Creating a healthier world for all starts with taking care of the one we all share. As one of America's Greenest Companies, we're always working to ensure our medicines are delivered in ways that safeguard the planet.
At Gilead, we innovate for impact. This commitment helps us drive scientific solutions forward, reach more people in more places and protect the planet we all share.
Congratulations to our very own Tomas Cihlar, Senior Vice President of Research, Virology, for being named to TIME's list of the 100 Most Influential People in the World.
Gilead is committed to using its virology expertise to advance HIV treatment and prevention to help end the epidemic. Since 2010, the company has partnered with Emory University in Atlanta to launch AIDSVu – an online mapping tool that visualizes granular data
At Gilead, we set and achieve bold ambitions in our fight against the world’s most devastating diseases. In this installment of The Centrifuge Sessions, See Phan, Vice President, Oncology Clinical Development
This year's Biomedical HIV Prevention Summit in Atlanta emphasized the importance of advancing prevention in the U.S. South, a region disproportionately impacted by HIV.
We’re focused on driving innovation in virology, oncology and immunology – and that includes investing in world-class science to change the way cancer is treated.
The deficit of Black male teachers in the United States is profound. According to the U.S. Department of Education, Black men comprise just 2% of all teachers. The Man the Bay fellowship offers a multi-pronged solution.
“In 2005, I began dreaming about starting a trans-led, immigrant-led organization,” she says. “My dream came true two years later when I started the nonprofit.”
Anu Osinusi recently spoke with us about how hepatitis research and treatment have changed over her career, why HDV is considered the “forgotten virus” and what’s next for Gilead.
Triple-negative breast cancer tends to be among the most aggressive forms of breast cancer. But today, Ricki is healthy and working to eliminate racial disparities through Touch: The Black Breast Cancer Alliance, a current Gilead grantee.
Dwaun Warmack is the president of Claflin University in South Carolina, one of the nation’s top 10 Historically Black Colleges and Universities (HBCUs), where his longstanding commitment to social justice aligns with the university’s foundation.
Congratulations to Taiyin Yang, EVP, Pharmaceutical Development and Manufacturing, for being elected to the 2022 class of the National Academy of Engineering.
While as a company, we have unsurprisingly always taken a clear stance against stigma, Gilead has prioritized its grant-making to support organizations working at the community level in recent years.
Gilead has launched a first-of-its-kind educational partnership with historically Black colleges and universities (HBCUs) and Hispanic-Serving Institutions (HSIs).
Gilead’s Corporate Social Responsibility (CSR) Report provides an overview of the work the company is doing around the world to improve the lives of...